Get an alert when AVAXMED LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

£301K

-22.4% vs 2024

Net assets

-£35M

-20.4% lowest in 6 filed years

Employees

0

Average over period

Profit before tax

-£7M

-18.9% lowest in 6 filed years

Accounts

10-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31

Metric Trend 2020-01-012020-12-312021-01-012021-12-312022-01-012022-12-312023-12-312024-01-012024-12-312025-12-31 Δ vs prior
Turnover £916,990£363,743 -60.3%
Operating profit -£3,713,362-£4,510,171 -21.5%
Profit before tax -£3,465,271-£3,636,935-£4,943,760-£4,353,321-£5,535,760-£6,581,072 -18.9%
Net profit -£3,465,271-£3,636,935-£4,943,760-£4,353,321-£4,913,881-£5,855,486 -19.2%
Cash £295,001£487,974£469,932£265,535£387,893£301,134 -22.4%
Total assets less current liabilities £2,675,953£1,984,294 -25.8%
Net assets -£10,557,121-£14,194,054-£19,137,811-£23,491,133-£28,723,795-£34,579,281 -20.4%
Equity -£7,091,850-£31,671,346-£10,557,121-£42,582,162-£14,194,054-£57,413,434£0-£23,809,914-£86,171,385£0 +100%
Average employees 000000
Wages £1,454,816£1,726,193£1,821,276£1,740,035£1,787,680£1,807,317 +1.1%
Directors' remuneration

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show . About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2020-01-012020-12-312021-01-012021-12-312022-01-012022-12-312023-12-312024-01-012024-12-312025-12-31
Return on capital employed -138.8%-227.3%
Gearing (liabilities / total assets) 482.5%443.7%577.1%762.3%898.8%1486.6%
Current ratio 1.61x2.34x
Interest cover -2.04x-2.18x

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.

Name history

Renamed 2 times since incorporation

  1. AVAXMED LIMITED 2025-09-08 → present
  2. AVAXZIPEN LIMITED 2023-01-04 → 2025-09-08
  3. ENESI PHARMA LIMITED 2017-08-09 → 2023-01-04

Audit & accounting basis

Accounting basis
IFRS
Reporting scope
Standalone (parent only)
Abridged
Yes — abridged accounts (limited disclosure)
Auditor
James Cowper Kreston Audit
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Directors believe, therefore, that the Company has sufficient cash to fund its operations for at least 12 months beyond the date of signing these financial statements. Consequently, the Directors believe it is appropriate to adopt the going concern basis of accounting.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

2 active · 7 resigned

Name Role Appointed Born Nationality
COHEN, Robin David Director 2023-02-16 Nov 1972 British
STODDART, Karen Lesley Director 2024-03-01 Aug 1957 British
Show 7 resigned officers
Name Role Appointed Resigned
LLOYD, Carol May Secretary 2021-09-27 2025-04-17
BONNET, Ludovic Gregoire, Dr Director 2018-11-12 2021-03-31
BUSH, Andrew James Director 2017-08-09 2021-12-15
EAGLING-VOSE, Elizabeth Sarah Director 2022-04-01 2023-03-31
HIPKISS, David John Director 2017-09-06 2022-07-25
MERCER, Carolyn Victoria, Dr Director 2024-09-24 2026-03-02
SCHMIDT, Meinhard Folkert Director 2017-09-06 2018-04-11

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Mr Anthony Taylor Rowlands Individual Shares 75–100%, Voting 75–100% 2017-08-09 Active

Filing timeline

Last 20 of 71 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2025-09-17 RESOLUTIONS Resolution
  • 2025-09-17 RESOLUTIONS Resolution
  • 2025-09-17 MA Memorandum articles
  • 2025-09-08 CERTNM Certificate change of name company PDF
Date Type Category Description
2026-03-27 AA accounts Accounts with accounts type full PDF
2026-03-02 TM01 officers Termination director company with name termination date PDF
2025-09-17 RESOLUTIONS resolution Resolution
2025-09-17 RESOLUTIONS resolution Resolution
2025-09-17 MA incorporation Memorandum articles
2025-09-08 CERTNM change-of-name Certificate change of name company PDF
2025-08-07 CS01 confirmation-statement Confirmation statement with updates PDF
2025-06-02 AA accounts Accounts with accounts type full
2025-04-17 TM02 officers Termination secretary company with name termination date PDF
2024-09-24 AP01 officers Appoint person director company with name date PDF
2024-08-08 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-08-01 CH01 officers Change person director company with change date PDF
2024-03-29 AA accounts Accounts with accounts type full PDF
2024-03-01 AP01 officers Appoint person director company with name date PDF
2024-03-01 CH01 officers Change person director company with change date PDF
2023-08-09 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-05-04 CH01 officers Change person director company with change date PDF
2023-03-31 TM01 officers Termination director company with name termination date PDF
2023-03-21 AA accounts Accounts with accounts type full PDF
2023-02-17 AP01 officers Appoint person director company with name date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
8

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page